EUVIMEDEUVIMED entdecken
VergleichsstudieMetaanalyseSystematische Übersicht

Remimazolam versus propofol for sedation in gastrointestinal endoscopic procedures: a systematic review and meta-analysis

Eduardo Cerchi Barbosa, Paula Arruda Espírito Santo, Stefano Baraldo, Gilmara Coelho Meine

British Journal of Anaesthesia · 2024-06 · 132 (6) · 1219-1229

DOI: 10.1016/j.bja.2024.02.005 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift British Journal of Anaesthesia, 2024-06. Verfasst von Eduardo Cerchi Barbosa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Evangelical University of Goiás, Anápolis, Brazil. Hauptthemen laut MEDLINE: Benzodiazepines, Endoscopy, Gastrointestinal, Hypnotics and Sedatives, Propofol. Die Arbeit wurde bisher 115-mal zitiert (Crossref) und nennt 52 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Propofol has a favourable efficacy profile in gastrointestinal endoscopic procedures, however adverse events remain frequent. Emerging evidence supports remimazolam use in gastrointestinal endoscopy. This systematic review and meta-analysis compares remimazolam and propofol, both combined with a short-acting opioid, for sedation of adults in gastrointestinal endoscopy. METHODS: We searched MEDLINE, Embase, and Cochrane databases for randomised controlled trials comparing efficacy-, safety-, and satisfaction-related outcomes between remimazolam and propofol, both combined with short-acting opioids, for sedation of adults undergoing gastrointestinal endoscopy. We performed sensitivity analyses, subgroup assessments by type of short-acting opioid used and age range, and meta-regression analysis using mean patient age as a covariate. We used R statistical software for statistical analyses. RESULTS: We included 15 trials (4516 subjects). Remimazolam was associated with a significantly lower sedation success rate (risk ratio [RR] 0.991; 95% confidence interval [CI] 0.984-0.998; high-quality evidence) and a slightly longer induction time (mean difference [MD] 9 s; 95% CI 4-13; moderate-quality evidence), whereas there was no significant difference between the sedatives in other time-related outcomes. Remimazolam was associated with significantly lower rates of respiratory depression (RR 0.41; 95% CI 0.30-0.56; high-quality evidence), hypotension (RR 0.43; 95% CI 0.35-0.51; moderate-quality evidence), hypotension requiring treatment (RR 0.25; 95% CI 0.12-0.52; high-quality evidence), and bradycardia (RR 0.42; 95% CI 0.30-0.58; high-quality evidence). There was no difference in patient (MD 0.41; 95% CI -0.07 to 0.89; moderate-quality evidence) and endoscopist satisfaction (MD -0.31; 95% CI -0.65 to 0.04; high-quality evidence) between both drugs. CONCLUSIONS: Remimazolam has clinically similar efficacy and greater safety when compared with propofol for sedation in gastrointestinal endoscopies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzodiazepinesEndoscopy, GastrointestinalHypnotics and SedativesPropofolHumansRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

benzodiazepineefficacyendoscopic sedationgastrointestinal endoscopypropofolremimazolamsafety

Substanzen

BenzodiazepinesHypnotics and SedativesPropofolremimazolam

Autor:innen und Institutionen

  • Department of Medicine, Evangelical University of Goiás, Anápolis, Brazil.
  • Diagnostic Imaging and Specialized Diagnosis Unit, University Hospital of Federal University of São Carlos, São Carlos, Brazil.
  • Department of Endoscopy, Barretos Cancer Hospital, Barretos, Brazil.
  • Division of Gastroenterology, Internal Medicine Department, Feevale University, Novo Hamburgo, Brazil. Electronic address: gilmara@feevale.br.

Zitieren

APA

Barbosa, E. C., Espírito Santo, P. A., Baraldo, S., & Meine, G. C. (2024). Remimazolam versus propofol for sedation in gastrointestinal endoscopic procedures: a systematic review and meta-analysis. British Journal of Anaesthesia, 132(6), 1219-1229. https://doi.org/10.1016/j.bja.2024.02.005

Vancouver

Barbosa EC, Espírito Santo PA, Baraldo S, Meine GC. Remimazolam versus propofol for sedation in gastrointestinal endoscopic procedures: a systematic review and meta-analysis. British Journal of Anaesthesia. 2024;132(6):1219-1229. doi:10.1016/j.bja.2024.02.005

BibTeX
@article{Barbosa2024,
  author = {Barbosa, Eduardo Cerchi and Espírito Santo, Paula Arruda and Baraldo, Stefano and Meine, Gilmara Coelho},
  title = {Remimazolam versus propofol for sedation in gastrointestinal endoscopic procedures: a systematic review and meta-analysis},
  journal = {British Journal of Anaesthesia},
  year = {2024},
  volume = {132},
  number = {6},
  pages = {1219--1229},
  doi = {10.1016/j.bja.2024.02.005}
}
Kostenlos starten →